World Lymphoma Day promotes early detection and research

September 15 marks World Lymphoma Day, an initiative by the Lymphoma Coalition to raise awareness about blood cancers affecting the lymphatic system and lymphocytes. The day aims to promote early diagnosis, scientific research, and public policy support for patient care.

Lymphomas are primarily categorized into Hodgkin and non-Hodgkin types. Common symptoms that often mimic other illnesses include persistent fever, night sweats, fatigue, unexplained weight loss, and swollen lymph nodes in the neck, armpits, or groin. Because these signs can be non-specific, medical experts emphasize the importance of seeking professional evaluation when symptoms persist.

Medical advancements, including immunotherapy and CAR-T cell therapies, have significantly improved survival rates. For instance, the Cleveland Clinic reports five-year survival rates of approximately 89% for Hodgkin lymphoma and 74% for non-Hodgkin lymphoma. Recent research from the University of Navarra also highlights how T-lymphocytes can play dual roles, either supporting or combating tumor cells depending on the specific lymphoma type.